Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Weiss

Showing results (191-200 of 213) with videos related to

Pageof 22
Sort By:
Paediatric Anaesthesia|November 10, 2012
Do lower cuff pressures reduce damage to the tracheal mucosa? A scanning electron microscopy study in neonatal pigsAnnette P N Kutter, Anne G Bittermann, Regula Bettschart-Wolfensberger, et al.
Intensive Care Medicine|February 26, 2008
Cardiac output measurement in children: comparison of the Ultrasound Cardiac Output Monitor with thermodilution cardiac output measurementWalter Knirsch, Oliver Kretschmar, Maren Tomaske, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
Spot-scanning proton therapy for malignant soft tissue tumors in childhood: First experiences at the Paul Scherrer InstituteBeate Timmermann, Andreas Schuck, Felix Niggli, et al.
Paediatric Anaesthesia|December 17, 2004
Tissue oxygenation monitoring during major pediatric surgery using transcutaneous liver near infrared spectroscopyMarkus Weiss, Gabriele Schulz, Ian Teller, et al.
Data in Brief|September 23, 2016
Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.
Clinical Pharmacology in Drug Development|June 17, 2016
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy VolunteersVeit J Erpenbeck, Eva Vets, Lien Gheyle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 4, 2022
Human Pharmacokinetics of LYS006, an Oral Leukotriene A4 Hydrolase Inhibitor Displaying Target-Mediated Drug DispositionBirk Poller, David Pearson, Luc Alexis Leuthold, et al.
Pulmonary Pharmacology & Therapeutics|June 14, 2019
Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypesBirk Poller, Ralph Woessner, Avantika Barve, et al.
Pulmonary Pharmacology & Therapeutics|June 30, 2016
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.
Journal of Clinical Pharmacology|January 25, 2006
Fingolimod (FTY720) in severe hepatic impairment: pharmacokinetics and relationship to markers of liver functionJohn M Kovarik, Robert L Schmouder, Stefan Hartmann, et al.
Pageof 22

Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Paediatric Anaesthesia|November 10, 2012
Do lower cuff pressures reduce damage to the tracheal mucosa? A scanning electron microscopy study in neonatal pigsAnnette P N Kutter, Anne G Bittermann, Regula Bettschart-Wolfensberger, et al.
Intensive Care Medicine|February 26, 2008
Cardiac output measurement in children: comparison of the Ultrasound Cardiac Output Monitor with thermodilution cardiac output measurementWalter Knirsch, Oliver Kretschmar, Maren Tomaske, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
Spot-scanning proton therapy for malignant soft tissue tumors in childhood: First experiences at the Paul Scherrer InstituteBeate Timmermann, Andreas Schuck, Felix Niggli, et al.
Paediatric Anaesthesia|December 17, 2004
Tissue oxygenation monitoring during major pediatric surgery using transcutaneous liver near infrared spectroscopyMarkus Weiss, Gabriele Schulz, Ian Teller, et al.
Data in Brief|September 23, 2016
Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.
Clinical Pharmacology in Drug Development|June 17, 2016
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy VolunteersVeit J Erpenbeck, Eva Vets, Lien Gheyle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 4, 2022
Human Pharmacokinetics of LYS006, an Oral Leukotriene A4 Hydrolase Inhibitor Displaying Target-Mediated Drug DispositionBirk Poller, David Pearson, Luc Alexis Leuthold, et al.
Pulmonary Pharmacology & Therapeutics|June 14, 2019
Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypesBirk Poller, Ralph Woessner, Avantika Barve, et al.
Pulmonary Pharmacology & Therapeutics|June 30, 2016
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.
Journal of Clinical Pharmacology|January 25, 2006
Fingolimod (FTY720) in severe hepatic impairment: pharmacokinetics and relationship to markers of liver functionJohn M Kovarik, Robert L Schmouder, Stefan Hartmann, et al.
Pageof 22